Here, we utilized brain-targeted LNP loaded with a novel Hv1 channel inhibitor, YHV984, to effectively alleviate the neuroinflammatory response post-IS
Its natural to wonder: How do these peptide therapies compare to GLP-1 agonists like semaglutide (Ozempic) or tirzepatide (the dual agonist Mounjaro)
Materials and methods Study design In this case-control study, we recruited 16 Afro-Caribbean patients with type 2 diabetes (7 patients without known microvascular complications and 9 with known complications) and 8 non-diabetic controls
Given that lipedema is characterized by significant microvascular impairment, incorporating a functional vascular component is essential for developing high-fidelity in vitro models
We also look at what some of the common side effects are and how common they occur
As such, we recommend making IV vitamin therapy a weekly treatment